Testosterone enanthate - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for testosterone enanthate and what is the scope of patent protection?

Testosterone enanthate is the generic ingredient in three branded drugs marketed by Endo Pharms, Eugia Pharma, Hikma Farmaceutica, Nexus, Rising, Watson Labs, Watson Pharms Inc, and Antares Pharma Inc, and is included in nine NDAs. There are twenty-three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Testosterone enanthate has ninety-seven patent family members in fourteen countries.

There are eight drug master file entries for testosterone enanthate. Three suppliers are listed for this compound.

Summary for testosterone enanthate

International Patents:	97
US Patents:	23
Tradenames:	3
Applicants:	8
NDAs:	9
Drug Master File Entries:	8
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	55
Clinical Trials:	39
Patent Applications:	4,145
Drug Prices:	Drug price trends for testosterone enanthate
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for testosterone enanthate
What excipients (inactive ingredients) are in testosterone enanthate?	testosterone enanthate excipients list
DailyMed Link:	testosterone enanthate at DailyMed

See drug prices for testosterone enanthate

Recent Clinical Trials for testosterone enanthate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
The University of Texas Medical Branch, Galveston	Phase 2/Phase 3
North Florida/South Georgia Veterans Health System	Phase 2
North Florida Foundation for Research and Education	Phase 2

See all testosterone enanthate clinical trials

Pharmacology for testosterone enanthate

Drug Class	Androgen
Mechanism of Action	Androgen Receptor Agonists

Anatomical Therapeutic Chemical (ATC) Classes for testosterone enanthate

G03BA	3-oxoandrosten (4) derivatives
G03B	ANDROGENS
G03	SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G	Genito-urinary system and sex hormones

US Patents and Regulatory Information for testosterone enanthate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	TESTOSTERONE ENANTHATE	testosterone enanthate	INJECTABLE;INJECTION	085599-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Watson Labs	TESTOSTERONE ENANTHATE	testosterone enanthate	INJECTABLE;INJECTION	083667-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Watson Labs	TESTOSTERONE ENANTHATE	testosterone enanthate	INJECTABLE;INJECTION	083667-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for testosterone enanthate

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018	⤷ Subscribe	⤷ Subscribe
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-001	Sep 28, 2018	⤷ Subscribe	⤷ Subscribe
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-003	Sep 28, 2018	⤷ Subscribe	⤷ Subscribe
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for testosterone enanthate

Subscribe to access the full database, or Subscribe
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	2019046582		⤷ Subscribe
Canada	2957679	AMORTISSEUR DE CHOCS POUR SERINGUE, DESTINE A ETRE UTILISE DANS UN DISPOSITIF D'INJECTION (A SYRINGE SHOCK ABSORBER FOR USE IN AN INJECTION DEVICE)	⤷ Subscribe
Japan	2023052550	テストステロン組成物の針に補助されるジェット注射投与	⤷ Subscribe
World Intellectual Property Organization (WIPO)	2015127012		⤷ Subscribe
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.